Literature DB >> 30652866

Superoxide Radical Photogenerator with Amplification Effect: Surmounting the Achilles' Heels of Photodynamic Oncotherapy.

Mingle Li1, Tao Xiong1, Jianjun Du1,2, Ruisong Tian1, Ming Xiao1, Lianying Guo3, Saran Long1,2, Jiangli Fan1,2, Wen Sun1,2, Kun Shao1,2, Xiangzhi Song4, James W Foley5, Xiaojun Peng1,2.   

Abstract

Strong oxygen dependence, poor tumor targeting, and limited treatment depth have been considered as the "Achilles' heels" facing the clinical usage of photodynamic therapy (PDT). Different from common approaches, here, we propose an innovative tactic by using photon-initiated dyad cationic superoxide radical (O2-•) generator (ENBOS) featuring "0 + 1 > 1" amplification effect to simultaneously overcome these drawbacks. In particular, by taking advantage of the Förster resonance energy transfer theory, the energy donor successfully endows ENBOS with significantly enhanced NIR absorbance and photon utility, which in turn lead to ENBOS more easily activated and generating more O2-• in deep tissues, that thus dramatically intensifies the type I PDT against hypoxic deep tumors. Moreover, benefiting from the dyad cationic feature, ENBOS achieves superior "structure-inherent targeting" abilities with the signal-to-background ratio as high as 25.2 at 48 h post intravenous injection, offering opportunities for accurate imaging-guided tumor treatment. Meanwhile, the intratumoral accumulation and retention performance are also markedly improved (>120 h). On the basis of these unique merits, ENBOS selectively inhibits the deep-seated hypoxic tumor proliferation at a low light-dose irradiation. Therefore, this delicate design may open new horizons and cause a paradigm change for PDT in future cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30652866     DOI: 10.1021/jacs.8b13141

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  19 in total

1.  Photoredox catalysis may be a general mechanism in photodynamic therapy.

Authors:  Mingle Li; Yunjie Xu; Zhongji Pu; Tao Xiong; Haiqiao Huang; Saran Long; Subin Son; Le Yu; Nem Singh; Yunkang Tong; Jonathan L Sessler; Xiaojun Peng; Jong Seung Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-15       Impact factor: 12.779

2.  Good Steel Used in the Blade: Well-Tailored Type-I Photosensitizers with Aggregation-Induced Emission Characteristics for Precise Nuclear Targeting Photodynamic Therapy.

Authors:  Miaomiao Kang; Zhijun Zhang; Wenhan Xu; Haifei Wen; Wei Zhu; Qian Wu; Hongzhuo Wu; Junyi Gong; Zhijia Wang; Dong Wang; Ben Zhong Tang
Journal:  Adv Sci (Weinh)       Date:  2021-05-21       Impact factor: 16.806

3.  An APN-activated NIR photosensitizer for cancer photodynamic therapy and fluorescence imaging.

Authors:  Xiao Zhou; Haidong Li; Chao Shi; Feng Xu; Zhen Zhang; Qichao Yao; He Ma; Wen Sun; Kun Shao; Jianjun Du; Saran Long; Jiangli Fan; Jingyun Wang; Xiaojun Peng
Journal:  Biomaterials       Date:  2020-05-03       Impact factor: 12.479

4.  Development of a novel anti-tumor theranostic platform: a near-infrared molecular upconversion sensitizer for deep-seated cancer photodynamic therapy.

Authors:  Ruisong Tian; Wen Sun; Mingle Li; Saran Long; Miao Li; Jiangli Fan; Lianying Guo; Xiaojun Peng
Journal:  Chem Sci       Date:  2019-09-11       Impact factor: 9.825

5.  Synergistic Anticancer Therapy by Ovalbumin Encapsulation-Enabled Tandem Reactive Oxygen Species Generation.

Authors:  Shuai Jiang; Ming Xiao; Wen Sun; Daniel Crespy; Volker Mailänder; Xiaojun Peng; Jiangli Fan; Katharina Landfester
Journal:  Angew Chem Int Ed Engl       Date:  2020-09-15       Impact factor: 15.336

6.  Cell membranes targeted unimolecular prodrug for programmatic photodynamic-chemo therapy.

Authors:  Jie Yuan; Rong Peng; Dongdong Su; Xingxing Zhang; Hepeng Zhao; Xiujuan Zhuang; Mei Chen; Xiaobing Zhang; Lin Yuan
Journal:  Theranostics       Date:  2021-01-19       Impact factor: 11.556

7.  Photoactivatable metabolic warheads enable precise and safe ablation of target cells in vivo.

Authors:  Sam Benson; Fabio de Moliner; Antonio Fernandez; Erkin Kuru; Nicholas L Asiimwe; Jun-Seok Lee; Lloyd Hamilton; Dirk Sieger; Isabel R Bravo; Abigail M Elliot; Yi Feng; Marc Vendrell
Journal:  Nat Commun       Date:  2021-04-22       Impact factor: 14.919

8.  A NIR-I light-responsive superoxide radical generator with cancer cell membrane targeting ability for enhanced imaging-guided photodynamic therapy.

Authors:  Yingcui Bu; Tianren Xu; Xiaojiao Zhu; Jie Zhang; Lianke Wang; Zhipeng Yu; Jianhua Yu; Aidong Wang; Yupeng Tian; Hongping Zhou; Yi Xie
Journal:  Chem Sci       Date:  2020-09-05       Impact factor: 9.825

9.  Hypoxia-activated NIR photosensitizer anchoring in the mitochondria for photodynamic therapy.

Authors:  Feng Xu; Haidong Li; Qichao Yao; Haoying Ge; Jiangli Fan; Wen Sun; Jingyun Wang; Xiaojun Peng
Journal:  Chem Sci       Date:  2019-10-02       Impact factor: 9.825

Review 10.  Enhancement of tumor lethality of ROS in photodynamic therapy.

Authors:  Lan Ming; Kai Cheng; Yu Chen; Rui Yang; Daozhen Chen
Journal:  Cancer Med       Date:  2020-11-03       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.